Citation

Nishiguchi GA, Rico A, Tanner H, Aversa RJ, Taft BR, Subramanian S, Setti L, Burger MT, Wan L, Tamez V, Smith A, Lou Y, Barsanti PA, Appleton BA, Mamo M, Tandeske L, Dix I, Tellew JE, Huang S, Mathews Griner LA, Cooke VG, Van Abbema A, Merritt H, Ma S, Gampa K, Feng F, Yuan J, Wang Y, Haling JR, Vaziri S, Hekmat-Nejad M, Jansen JM, Polyakov V, Zang R, Sethuraman V, Amiri P, Singh M, Lees E, Shao W, Stuart DD, Dillon MP, Ramurthy S.: Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers. J Med Chem, Volume 60 (12), 2017

Authors

Amiri P, Appleton BA, Aversa RJ, Barsanti PA, Burger MT, Cooke VG, Dillon MP, Dix I, Feng F, Gampa K, Haling JR, Hekmat-Nejad M, Huang S, Jansen JM, Lees E, Lou Y, Ma S, Mamo M, Mathews Griner LA, Merritt H, Nishiguchi GA, Polyakov V, Ramurthy S., Rico A, Sethuraman V, Setti L, Shao W, Singh M, Smith A, Stuart DD, Subramanian S, Taft BR, Tamez V, Tandeske L, Tanner H, Tellew JE, van Abbema A, Vaziri S, Wan L, Wang Y, Yuan J, Zang R

Journal

J Med Chem

Year

2017

DOI

10.1021/acs.jmedchem.6b01862

PubMed

28557458

Machine-readable

REST APIRDF